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Abstract
In many developing countries, a large percentage of the population lacks access to adequate
healthcare. This is especially true in India where close to 70% of the population lives in rural
areas and has little to no access to hospitals or clinics. People living in rural India often times
cannot afford to pay to see a doctor should they need to make the journey to a hospital.
Telemedicine, a breakthrough in the past couple decades, has broken down the barrier between
the patient and the physician. It has slowly been implemented in India to make doctors more
available to patients through the use of video conferences and other forms of communication.
A compact and affordable kit has been developed that will be used to take a patient’s blood
pressure, heart rate, blood glucose concentration and oxygen saturation. Our most novel
contribution is the non-invasive glucose sensor that will use a near-infrared LED and photodiode
in the patient’s earlobe. Currently millions of diabetics do this by pricking their finger. By
wirelessly sending data results from the vital sign kit, the first essential part of a treatment can be
carried out via wireless communication, saving the doctor and patient time and money.
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Chapter 1: Introduction
1.1 Background
In many developing countries, a large percentage of the population lacks access to adequate
healthcare. This is especially true in India where close to 70% of the population lives in rural
areas and has little to no access to hospitals or clinics. In addition, the doctor to patient ratio is
0.7 to 1000 [1], meaning a large percentage of the population in India has no access to a doctor
or clinic [2]. This means that people living in rural India are left without access to a nearby
hospital and often times cannot afford to pay to see a doctor if they do make the journey to a
hospital [3]. Telemedicine, a breakthrough in the past couple decades, has broken down the
barrier between the patient and the physician. Telemedicine has slowly been implemented in
India to make doctors more available to patients through the use of video conferences and other
forms of communication. According to Amrita Pal, telemedicine is highly needed for India’s
rural population. Currently, patients usually have a late diagnosis of their illness, cannot get to
their care provider in time, and do not get the treatment they need from the right providers [4].
However, a shortcoming of this is that the doctor still has no direct access to a patient's
information, other than descriptions, x-rays, etc.
1.2 Project Goal
Our objective is to develop a kit equipped with sensors that will be used to take a patient’s vital
signs, such as blood pressure, heart rate, blood glucose concentration, and blood oxygen
saturation. It will be inexpensive and accessible to people in rural areas of developing countries.
In such scenarios, this device would replace the first steps of any standard medical checkup.
Instead of traveling all the way to a hospital to have baseline vitals measured, you would
measure them with this device, and send them to a physician for review to help determine
whether an in-person appointment is necessary. This frugal device gives under-resourced
families the opportunity to take care of their health and live a better life. Although our device
could be applicable in almost any region with lack of access to healthcare, we believe India
would be the region that would benefit the most from our device, which is why most of our
research and project will focus with India in mind.
By having a medical kit that takes many important vital signs, even people who do not have
insurance or easy access to a hospital will be able to monitor their own vital signs and those of
their family members. This solution is better than others currently available because it is much
smaller, cheaper, and more intuitive in design and use. Current devices include carts that are used
in most hospitals here in the US, that are about three feet tall, and cost in the range of hundreds
to one thousand dollars. An example of this commercial monitor is the Welch Allyn Vital Sign
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Monitor that is commonly used in hospitals, at the price of $300 [4]. There are a number of other
available devices, but they are expensive, and generally only have one or two types of sensors.
FDA approved pulse oximeters only have one function of measuring oxygen saturation, yet they
cost about $100. The proposed device is targeted to cost no more than $150, will contain at least
four sensor types, and be connectable to a mobile device such that data can be sent wirelessly to
a physician via Wi-Fi or SMS. Communities can share multiple vital sensor kits and split costs
accordingly to make the device even more affordable. We strongly believe that by making this
device low-cost and simple to use for developing countries, communities and families will be
much happier and healthier because they will be able to get the medical attention they need from
doctors without having to have the financial burden of paying for multiple hospital visits and
transportation costs.
1.3 Review and Critique of Literature
Device from 2015-16 Senior Design
The device produced by last year’s team had similar goals to this year’s team, with the exception
of an additional parameter. Their device focused on blood pressure, pulse oximetry, and heart
rate measurements [6]. While the blood pressure measurements were relatively accurate, there
was notable error with the other two parameters, especially the pulse oximeter, which retained an
error of 13% relative to commercial pulse oximeters. This team was also unable to reach the
stage of connecting to a mobile device for sending data. The final prototype of last year’s team’s
device is shown in figure 1. As stated above, this year’s team seeks to utilize the prototype from
last year’s team as a baseline, and seeks to improve it by:
● Adding additional sensor (blood glucose monitoring)
● Changing the Arduino Mega microcontroller and breadboard to a PCB method
● Integrating device with mobile system for sending data
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Figure 1-1: Last Year’s Team’s Final Prototype
With these additional sensors added to the device, it will serve as a more accurate diagnostic
tool, such that physicians can get a better idea of the condition of the patient, to better determine
the best intervention without requiring the patient to necessarily make an expensive and tedious
journey all the way to a hospital.
Without yet having spoken directly with the potential users of this device, research has been
done into rural parts of India, to examine as a case study what sorts of illnesses are prevalent, in
order to determine what sorts of sensors would be of greatest use to the users. For example, were
cardiovascular disease to be very rare in rural India, it would be a waste of resources to make
efforts to include a blood pressure sensor in the device, as that is the primary function of that
particular sensor[7]. Upon examination, there is prevalence of lung disease, cardiovascular
illnesses, and diabetes in India, which lead to our inclusion of the blood pressure sensor for the
cardiovascular illnesses, the pulse oximeter for lung disease, and a blood glucose meter for the
diabetes.[8]
1.4 Sensor Designs
Commercially available vital sensor devices are quite expensive, with accurate and reliable
individual sensors each costing well over one hundred USD each. There are also devices, such as
those currently used in hospitals, which are multi-sensor “carts” which cost over one thousand
USD for the cart. For this reason, it was decided by this year’s team that in order to make a more
frugal device, different designs would be needed to reduce the overall cost of the device, while
still maintaining accuracy and efficiency. This involves learning the inner workings of how
commercial sensor devices, and replicating these functions with less expensive parts, and making
up for discrepancies in more expensive technologies with simplistic yet effective hardware and
software enhancing and filtering systems.
1.4.1 Proof of Concept Sensors
Included among the sensors that this year’s team is connecting to the device is the non-invasive
blood glucose meter, which is not yet commercially available. However, due to the high demand
for a sensor of this kind and its relevance to rural India, it was determined that this sensor would
be very useful to include in the device.
Given the fact that this sensor is not commercially available, it is to be constructed from proof of
concept designs found in various journals. For the non-invasive blood glucose meter,
near-infrared light functions in a way that is similar to the pulse oximeter, which is to use light
transmittance as a means of measurement, as the transmitted light is linearly correlated to the
blood glucose levels [9]. Given the prototype-nature of this sensor, it may be prone to error.
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However, should they be functional, they would serve as incredible tools to serve the rural
communities of India.
1.4.2 Non-Invasive Glucose Meter
As of 2008, there were thirty-nine companies doing active research and development with the
purpose of producing a functional, commercially viable non-invasive glucose monitoring
system[10]. Of these thirty-nine, nineteen were focused on utilizing some form of spectroscopy,
with eight of them pursuing near-infrared spectroscopy. There is also a wide range of parts of the
body focused upon for the measurement of the blood glucose concentrations, ranging from tears
measured by contact lenses to forearm skin. As of 2016, there are at least two companies that are
in the process of receiving FDA approval for their devices[11]. It appears that this technology is
not too far from the market, but these devices will likely be very expensive, due to the extremely
high demand for a non-invasive glucose meter.
1.4.3 Telemedicine Multi-Sensors
Today, there are no telemedicine multi-sensors of the variety that we are producing on the
market. However, there is one company that is expected to receive FDA approval in 2017 called
MedWand[12], which is an all-in-one sensor that measures heart rate, blood oxygen saturation,
temperature, and serves as a digital stethoscope and camera as well. This device has a very
similar mission to that of our device, to save the patient time and money, and provide data to a
doctor that is engaging with telemedicine. However, the MedWand is expected to be more
expensive than our device, and also does not come with a method for measuring blood pressure
or blood glucose, although it has bluetooth capabilities that allow for connection to bluetooth
enabled blood glucose meters and blood pressure monitors. The lack of these sensors would
further increase the price of the device if one was to purchase additions for the MedWand, and
requires the use of a computer or tablet. This involves a bit of an access barrier, as there are
fewer people that have regular access to a laptop or tablet than there are those who have
smartphones. This is particularly true in areas outside the United States, such as rural India,
which has a well established cell phone infrastructure, but less access to computers.
1.5 Expected Results
The end goal of the product is to be able to successfully measure blood pressure, blood oxygen
saturation, heart rate, and blood glucose concentration of a patient within 5% error. There are
two physical sensors to be built that are to be used to gather the data for the patient in question.
The above four vitals signs are to be measured with an ear clamp sensor and a blood pressure
cuff. The measured results are to be measured and displayed on an external device, such as a
mobile device or computer. The expected results we hope to gain are accurate readings of the
four vital signs that are able to be read easily by the user. We expect to make a fairly easy to use
device that is intuitive to use by the user.
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1.6 Backup Plan:
For the Oximeter, we have ensured that if our ear lobe clamp in development does not work, we
can quickly modify the PCB to at least be able to connect and use a Nellcor DS-100A sensor.
The Nellcor DS-100A, is a finger clamp that we can use to implement an oximeter with our
designed PCB. By measuring at least 2 of the vital signs desired and we can move forward with
the data transmission part of the project. At the same, we could use a breadboard and Arduino
Uno board to altogether create a different circuit for our sensor, in case there is a small but
salvageable error in our design. While it would be expensive to acquire a Integrated Analog
Front End for Pulse Oximeters (AFE4490), we also have that option, which would allow us to
replace our overall circuits and use the AFE4490 to drive the LEDs for the Oximeter and
possibly the Blood Glucose sensor. The back up plan for the Blood Pressure Sensor is to use a
breadboard and Arduino Uno combination.
1.7 Significance
The successful completion and implementation of this project will bring further scientific
progress to making healthcare affordable. In addition, a major component of this project is that
blood glucose will be able to be detected non-invasively, which will completely transform the
way diabetics monitor their blood sugar levels. This device that affordably measures the
important vital signs [13] and blood sugar levels will ultimately help many people in poverty be
able to take care of family members and also communicate to health experts more easily.
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Chapter 2: System Level
2.1 System Level Overview

Figure 2-1: System Level Overview
2.2 System Level Requirements
In order to make a well-rounded product, there were various concerns that needed to be
addressed in the creation of our device.
Table 2-1: Economic, Ethical, and Ergonomic Considerations
Consideration

Reasoning

Device Requirement

Commercial
Cost

Device should be
affordable so that
communities are able
to buy it in developing
countries, specifically
India.

- Maximized efficiency of components
- Total cost of device should not exceed $200

Ethical
Concern for
Device not to
Harm Patient

Use of the medical
device should not
cause negative side
effects or hurt patient

- Add in acrylic plastic between LED and skin to
eliminate skin-electronics contact.
- LED wires of device are insulated so that patient
does not touch them.

Manufacturing The materials should
Consideration be environmentally
sound and affordable.

- Material chosen should be affordable, non-toxic,
and recyclable to eliminate waste.
- Device should be able to be intuitively put
together to optimize manufacturing process.
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2.3 Benchmarking Results: The major goals of our project was to create a device that is simple
to use and affordable for the communities where aim to introduce our device. At the same time
the device needs to as accurate as most commercial individual sensor alternatives in the market,
to ensure it meets the standards of safety. Taking into consideration the necessity for our device
to be connected to a cell phone to transmit the data, another goal was to ensure that the device
can connect to most mobile devices in the market, however, due to the capabilities of a
smartphone over a regular mobile device we aimed to prioritize the smartphone compatibility of
our device due to time constraints.
Accuracy: Because of the importance of taking the vital signs correctly, accuracy is one of the
major requirements in our device. The way we went about ensuring we obtained our desired
accuracy for each of our sensors is that we bought a market alternative for each sensor to have
something to compare our measurement data to. Each market alternative was chosen based on
price range and reliability of the device based on professional reviews. Our goal then was to
ensure that each of our sensor measurements was within a 5% error margin of the measurements
from the market alternative.
Price: In terms of price, something to consider is that our device needed to be as affordable as
possible from the perspective of the community we want to introduce it to. India only spends
around 4% of it’s GDP in healthcare, around half of the average percentage spent by most
countries [1]. Therefore most patients have to pay from pocket to be able to see a doctor and
paying for private healthcare is really expensive. Taking this into consideration our goal was to
make our device cost to be between $100-$150 which is roughly the price of a cell phone in
India (7000-1500 rupees is the range of prices for low to high end cell phones) [18]. With the
idea that mass manufacture of our device would drive the price even further down and that our
business plan is centered around the idea of a whole community using our device, we saw this
range of prices as quite affordable for a community.
Portability: One of our aims was to make the device as small and light as possible so that it can
be carried by any adult or teen in a moderate size backpack or bag. The encasing for the device
previously developed was about 8x6x4 inches, the reason for this size has mostly to do with the
size of the breadboards used for the controller. For our controller we aimed to use a PCB board
which would be a lot smaller and therefore not need as much space. Overall our project should
be easy to carry and fit in any moderate size backpack or purse.
Simplicity: T
 he communities that we are aiming introduce our device to might not have any
knowledge of how to use each sensor separately. One possible solution we looked into
developing, is to possibly add a manual or a set of instructions on how to use our device. Taking
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into consideration the business plan for our device, this set of instructions would be for an
individual that together with a bit of training should be capable of using the device. Because of
the language differences, we would need to rely on images or very short phrases that will give
some background information on how to use the device. While each sensor is not hard to use if
having some knowledge of how it works, a manual would ensure the patient has some
understanding of how to use it. Since we our aim was to make each sensor in our device very
similar to their more well known market alternatives, a medical professional should be able to
use it quite comfortably.
Mobile Phone Penetration: Our decision to use a cell phone for wireless communication as
opposed to a PC is that we took into consideration the mobile phone penetration rate vs PC
penetration of the region. While PC penetration is only at 9% in India, meaning 9% of the
population has access to a PC or knows how to use one, the mobile market is at an impressive
%80 in comparison[18]. Furthermore, India is now considered the second largest mobile market
in the world, with an estimated 900 million mobile connections.
Smartphone Compatibility: It is important to take into consideration the difference between
any mobile device and smartphones. While around 80% of the population in India owns some
form of mobile device, only 30% of those devices are smartphones[18]. This percentage is
expected to increase, however, and as it currently stands it forced us to consider whether our
device needed to be developed for a smartphone device or for any mobile device. A smartphone
device would be certainly easier to use since there are already many apps that have similar
functions to what we need to create. However, if we made our device capable of transmitting the
information through a non-smartphone device it would follow that it could be easily used by a
smartphone device and therefore our device would be easier to integrate and use in any
community. Taking into consideration this information, our goal was to formulate a plan to
connect our device with any mobile device, if this proved to be too difficult then we would move
towards using a smartphone as the means of communication for our device.
2.4 Functional Analysis
Table 2-2: General and Specific Functions of Each Device Component
Subsystem (Top down)
Overall Prototype
(PCB + Ear Sensor + Blood Pressure Sensor)

PCB & Arduino Uno

Function
This system works together in conjunction
with a computer to be able to send the data
from the sensor to Arduino to Matlab for
processing.
The PCB is the heart of the device, where all
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the electrical circuits needed for the sensors
are located.
Ear Sensor, Blood Pressure Sensor, Glucose
Sensor

The ear sensor is composed of three LEDs
and two photodiodes. It is housed in an ABS
3D printed ear clamp. The glucose sensor is
also housed in the ear clamp.
Blood pressure sensor is connected on one
end to the PCB and to the cuff/pump on the
other end.

2.5 Team and Project Management
This project required thorough organization, communication amongst team members and
with our advisors throughout the whole school year. We kept organized by taking notes during
meetings and keeping a gantt chart to stay on top of deadlines [refer to Appendix E]. A challenge
that was encountered at some points throughout the project was working to build an affordable
device that also could provide accurate results. The budget for this project was $668. The
glucose sensor was the most experimental for the vital sign kit, and resultingly, the electrical
components were very expensive. We dealt with this challenge by only buying what we were
able to with our funding options and buying more components if all others were non-functional.
In addition, having a small budget to ensure the device stayed at a low overall cost taught us to
thoroughly research the properties of the electrical components used so that we have optimal use
of our device.
Furthermore, the design process continued to evolve throughout the school year. The
main sections that were needed at the beginning were the electrical circuits for the blood
pressure, pulse oximeter and glucose sensor. Then, the ear clamp housing was designed to put
the device together. As we tested our device with several patients, we noted how we can improve
the ear sensor and PCB housing to make the product more compact and easy to use.
2.6 Risks
This project did not pose a risk to any people that use the product. In order to use the
medical device on other patients, we had to be approved by the Santa Clara Institutional Review
Board. This involved an extensive application with details on why, how, and what we intended to
test. We did trainings and also require consent forms for patients to sign before they could be
tested. For testing people’s heart rate, we do require that the person do a form of moderate
exercise for 30 seconds to get the heart rate elevated. If for some reason the patient suffered an
injury for this part of testing, that would be our major concern. There is no danger in being tested
for blood sugar, glucose and oxygen saturation because it is all non-invasive.
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Chapter 3: Subsystems Level
3.1 Blood Pressure Sensor
3.1.1 Role/Requirements
The blood pressure sensor functions based on the fluid pressure found in the patient’s arterial
walls. There are two points of interest to be monitored as the patient’s heart beats: When the
patient’s heart is contracted a high pressure is to be monitored, which is known as the systolic
pressure, and when the patient’s heart is relaxed, the lower pressure, known as diastolic pressure
can be measured. The blood flowing through an artery between these systolic and diastolic
pressures causes vibrations in the arterial wall that can then be detected and measured through
voltage signals[14].
3.1.2 Options and Trades
Since this project was an adaptation of the previous year’s prototype, we decided to work with
the current blood pressure cuff and pressure transducer to reduce the price of purchasing new
components. These components functioned well on their own and their accuracy outweighed the
cost of purchasing new components [See Appendix F for components].
3.1.3 Design Description
The initial approach was to reconstruct the blood pressure circuit from breadboard design that it
was previously implemented on. This included recreating the blood pressure circuit on a
breadboard to begin with, as the previous team did not leave proper schematics for our referral.
The main blood pressure schematic that became our reference is shown below in Figure 3-1. This
was taken from Freescale’s articles on design of medical devices [17]. [See Appendix D for
ExpressPCB designs]

Figure 3-1: Freescale Blood Pressure Circuit Design

19

As we referred to this ideal schematic, our breadboard design began to come together with our
various components. The approved circuit design at our first stage of testing is shown below in
Figure 3-2.

Figure 3-2: Breadboard Blood Pressure Circuit Design
3.1.4 Supported Analysis
The overall process of blood pressure testing began once the circuit implementation was
completed. The design was finalized into the PCB schematic implementation and final testing
began once our overall PCB was constructed. Results from both our group and various test
subjects can be seen in Appendix C.
3.1.5 Test Procedures
The testing procedures for the blood pressure followed the testing procedure that would be
encompassed in all of our sensors. Our patient would first take their blood pressure from our
commercialized blood pressure sensor, so that we would have a baseline to compare their results
against our prototype. Once this was done, our patient would use our blood pressure cuff so that
we could measure our own data through our device. As a group member would manually pump
the blood pressure pump, corresponding data would appear through our Arduino code. An
example plot is shown below in Figure 5.

20

Figure 3-3: Arduino Plotted BP Results
The above plot would then correspond to data points that would be measured through Excel.
These data points would then be converted into a plot to be analyzed to find the patient’s
corresponding systolic and diastolic values. An example to this data is shown in Appendix A.
The bumps on the right half of the plot correspond to the patient’s heart rate and this data can
also be measured through the blood pressure analysis.
3.2 Glucose Sensor
3.2.1 Role/Requirements
This subsystem is the non-invasive blood glucose sensor. It functions to measure the blood
glucose concentrations of a patient. The requirements for this sensor are as follows:
● Non-invasive (no blood draw, no damage to patient tissue)
● Accurate measurements (as measured on glucose standard solutions)
● Small in size (to fit in the ear sensor with the pulse oximeter)
3.2.2 Options and Trades
Options for the development of this sensor were very limited. Due to the experimental nature of
this technology, there are very few companies that sell the components that could be used to fit
the determined design for this device. The reason for choosing the wavelength of LED that we
did is due to the maximized glucose interactions, and minimized water interactions while still
maintaining a feasible path length (see figure 3-7). The photodiode was selected based on its
ability to absorb the desired wavelength (see Figure I-2, in Appendix I), its cost, and its size.
Since the purpose of the device as a whole is to be portable and inexpensive, the size would need
to be minimal and its price be as low as possible as well.
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3.2.3 Design Description
The glucose sensor is composed of a single near-infrared (NIR) LED that emits a wavelength of
1550 nm, and a light receiver, in this case being a photodiode that receives the 1550nm
wavelength. These two components are positioned within the ear sensor, with the NIR LED
positioned on the same side as the pulse oximeter LEDs, and the photodiode positioned on the
same side as the pulse oximetry photodiode, with them positioned directly across from each
other.

Figure 3-4: 1550nm LED

Figures 3-5: Glucose Photodiode [21]
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Figure 3-6: Glucose LED and photodiode in place in ear sensor housing
The novelty of this approach is the non-invasive nature. While normal sensors require exposure
and direct testing of patient blood, the spectroscopic nature of the NIR LED-photodiode method
removes the need for any tissue damage, or need for direct exposure to body fluids. Instead, the
1550 nm wavelength is able to pass through the tissue of the patient with minimal interactions
with the water (see figure 3-7) and tissue components [9] of the patient, and maximal interactions
with the glucose dissolved in the blood, while maintaining a path length great enough to travel
through the entire tissue, in this case being the ear lobe. This method reduces sanitation concerns,
reusability concerns, as well as general safety and health concerns for the patient associated with
the testing process relative to commercially available methods.

Figure 3-7: Absorbance spectra of glucose vs. water [22]
Glucose molecules reflect light at a wavelength of 1550 nm, indicating that as the glucose
concentration increases, the amount of light received by the photodiode on the other side of the
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tissue or glucose solution is reduced, as more of the NIR photons are reflected back towards the
LED instead of passing all the way through the tissue or solution.
3.2.4 Supporting Analysis and Test Procedures
The glucose sensor was tested by using several glucose solutions in water of a predetermined
concentrations to obtain raw voltage readings from the device, and then correlating each of those
glucose solutions to their respective glucose solutions to produce a standard curve. This standard
curve would then be used to correlate voltage readings from patients to the appropriate blood
glucose levels. The glucose solutions used were in units of milligrams per deciliter: 30, 50, 70,
80, 90, 100, 125, 150, 200, 2000. These particular concentrations were selected for their
physiological relevance; 70-100 mg/dL is generally considered to be a healthy blood glucose
concentration before eating a meal, and 30 and 50 mg/dL are both considered very low blood
glucose concentrations (hypoglycemia). 125, 150, and 200 mg/dL are all considered to be high
blood sugar (hyperglycemia). 2000 mg/dL was a concentration selected in order to ensure the
sensor was responsive, and to help detect the linearity of the standard curve.

Figure 3-8: Glucose solutions in glass bottles. Arranged left to right; 30, 50, 70, 80, 90, 100, 125,
150, 200 mg/dL
The glucose solution was put into a small container composed of black acrylonitrile butadiene
styrene (ABS) plastic and transparent acrylic plastic. This container was a small box in which the
glucose solution was put in to provide a fixed path length (5mm) for the glucose LED and
photodiodes to be placed against. Each glucose solution was put into the black box for
measurement by the glucose sensor to form the standard curve.
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Figure 3-9: Black glucose solution testing box in testing
The standard curve produced by our device did not provide data to support a linear correlation
between the glucose concentration and the voltage output of the glucose sensor, following
several attempts throughout the academic year. One of the last trials did produce a correlation,
but following trials were not able to replicate those results.

Figure 3-10: Trial 1 of Glucose sensor
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Figure 3-11: Trial 5 of Glucose sensor
The expected results based on literature research is that with the increasing glucose
concentrations, the voltage output by the glucose photodiode would be reduced, as the
transmission of light is reduced with the greater number of glucose molecules blocking the path
of the 1550 nm photons. However, the data retrieved by the glucose sensor demonstrate a
seemingly random voltage output for each glucose concentration, instead of the expected
negative correlation.
3.2.5 Verification
Due to the nature of the glucose sensor we produced, it is non-invasive; it does not require direct
access to blood or damage to body tissues for measurement to occur, thereby meeting the
requirement of being non-invasive. However, following the various tests performed on the
sensor, no accurate replicable standard curve was obtained, thereby indicating a lack of accurate
glucose measurements. The size of the sensor, on the other hand, was appropriately sized, and
was able to fit into the ear sensor, eliminating the need to make a separate housing/sensor for the
glucose sensor to be an independent component.
3.3 Pulse Oximeter
3.3.1 Roles and Requirements
The device is intended to be compact, simple, and accurate.
Requirements:
● Ear lobe is designated path for oxygen saturation measurement because of less
light reflection and diffraction (no bones or thick tissue for light to penetrate).
● Non-invasiveness is required to limit harm to patient and improve ease of use.
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● Affordability of pulse oximeter components allows for overall price of device to
stay low.
3.3.2 Options and Trades
When considering how to design this sensor, we could have chosen the finger or the ear.
However, since we wanted to have multiple sensors on one clamp, we chose to design our device
based on the decision of testing through the earlobe. There was no ambiguity in the types of
LEDs that we could have used because literature has shown that 650 nm and 940 nm
wavelengths will yield the best results in calculating oxygen saturation levels. For the chosen
photodiode, there were multiple options in the market, but the one that was chosen was based on
what the previous year’s team did. This photodiode worked well in the preliminary testing and
was kept for final testing.
A pulse oximeter measures the oxygen saturation in the blood stream. Oxygen is necessary for
the body’s survival, and so it is an important sign to keep track of. Hemoglobin is a molecule that
transports oxygen molecules to the desired locations. The way this is done with our device is one
of the most common methods of detection, light spectroscopy.

Figure 3-12: Two-LED pulse oximeter setup. Two LEDs and a photodiode (receiver of light) to
detect oxygenated and deoxygenated blood cells. [23]
There are two LEDs that are used to measure the oxygenated hemoglobin and deoxygenated
hemoglobin in the blood stream. Commercial devices often test oxygen saturation through the
finger, but our device tests through the ear. This should have no impact on the oxygen saturation
measurement. The ear was chosen to be tested because there are no bones in the earlobe and this
limits light scattering. Two LEDs, at wavelength 650 nm and 940 nm were chosen because
literature shows that red light is most absorbed by deoxyhemoglobin and least absorbed by
oxyhemoglobin, while at 940 nm, oxyhemoglobin has the highest absorption and
deoxyhemoglobin has the least absorption.
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Figure 3-13: Oxyhemoglobin vs. deoxyhemoglobin absorption spectra [23]. This image shows
the maximal absorption of oxyhemoglobin and deoxyhemoglobin at different path lengths. 650
nm (red light) and 950 nm (infrared light) LEDs were chosen because of their optimal results.
Data is taken with each LED in which the arterial blood flow is measured. The relationship
between the absorbance of oxy- and deoxy-hemoglobin is quantified to calculate the oxygen
saturation. The data is taken from the LED readings and then uploaded to Matlab for further
processing. [Refer to Appendix A for Matlab code].

Figure 3-14: Pulse oximeter equation. This equation calculates the oxygen saturation by taking
the log of the number of peaks (AC component only) for the red LED divided by the log of the
number of peaks (AC component) of the infrared LED. This ratio is multiplied by 100 to get the
final oxygen saturation percentage.
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3.3.3 Design Description

Figure 3-15: Pulse oximeter components. The main components needed for the pulse oximeter
are shown above: 650nm LED (top left), 940nm LED (top right), OPT101 Texas Instruments
photodiode (bottom).
The circuit design for the pulse oximeter was based on Freescale’s articles on medical devices
[16]. The circuit design is shown in Figure 3.16 below. [See Appendix D for ExpressPCB circuit
design].

Figure 3-16: Freescale Pulse Oximeter Circuit Design
Initially out testing of the circuit design was done on a breadboard and then the circuit design
was implemented in a 4 layer PCB. Please refer to Appendix C & D for details on circuit design
and implementation.
3.3.4 Supported Analysis and Testing Procedures
The pulse oximeter testing was conducted in two states, with a resting and elevated heart rate.
Testing oxygen saturation and heart rate both when a patient is at rest and then after doing
moderate exercises further broadens the ability of the sensor to be able to accurately detect
oxygen saturation and heart rate.
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Figure 3-17: Initial pulse oximeter testing setup. Red shining LED with photodiode across it
(also shining in red). Finger was placed in gap between LED and photodiode.
Initially, testing oxygen saturation with the device prototyped on the breadboard was difficult
because there was not a set path length and the finger was put between an LED and photodiode
to see if the arterial blood flow could be detected. The finger was initially tested because the ear
clamp SolidWorks design had not yet been created. Arduino serial plotter was used to get
real-time results of arterial blood flow when finger was placed between LED and photodiode.

Figure 3-18: Finalized pulse oximeter testing setup. The finalized testing setup with fixed path
length between LEDs (red LED is shining) and photodiode.
The final testing setup was used with the ear clamp to house the LEDs from outside light as best
as possible, and the photodiode on the other half of the ear clamp. In addition, the LED’s were
directly connected to the PCB (no longer designed on a breadboard).
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Table 3-1: Pulse oximeter and heart rate data from trial 1.

Oxygen saturation and heart rate were tested six different times, where the average error of both
the heart rate and oxygen saturation are under ten percent compared to commercial products.
There are promising results from this sensor; the next step is to test the pulse oximeter accuracy
when the patient has an elevated heart rate.
Table 3-2: Pulse oximeter and heart rate data from trial 2.
Percent Difference Patient 0
HR:

Resting

35%

Elevated

11%

Percent Difference Patient 1
HR:

Resting

6%

Elevated

n/a

Percent Difference Patient 2
HR:

Resting

1%

Elevated

2%

Note: The heart rate was calculated in MATLAB from the LED raw data [Refer to Appendix A
for further detail].
There is an outlier in this data set where Patient 0 has a resting heart rate difference of 35%. This
is the only point where this has occurred, and it is hypothesized that the error is because of the
sensitivity of the commercial sensor. However, the average error for the elevated heart rate is
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6.5% for two out of the three patients. Patient 1’s elevated heart rate could not be calculated
because one of the data sets did not save correctly and could not be processed.
3.4 Microcontroller
3.4.1 Role/Requirements
An essential component in our device is a microcontroller that is able to take in the analog
signals of each of our sensors and transform the signal into a digital signal. The digital signal is
then is then analyzed by the software of the device connected into the microcontroller and turn
into the calculations of the measurements of the patient’s vital signs. At the same time there are
filters, amplifiers and buffers that need to be implemented to clean the incoming signal from
each of our sensors.
3.4.2 Options and Trades
Taking the requirements into consideration we decided on a set of possible implementations for
our microcontroller and the implementation of our circuit designs:
● Breadboard and Arduino Uno: What the previous team did was to implement all of the
circuit designs into a breadboard and connect this breadboard to the sensors and to an
Arduino Uno Microcontroller. This method of implementation had a number of issues
since the breadboard components could fall off and had a greater error margin in treating
the signals. At the same time, while the Arduino Uno is an excellent microcontroller that
could supply all the needs of the project, it is also a component that is relative expensive
to the overall project.
○ Pros
■ Easy to Implement
■ Easy to modify
■ Inexpensive implementation of circuit designs
○ Cons
■ Expensive microcontroller
■ Wide error margin with measurements
■ Convoluted wiring and loose parts in implementation of circuit design
● PCB: Taking into consideration what the previous team did, we decided that the best
solution was to design and order a PCB that included all of our circuit designs, as well as
the required components to implement a simpler microcontroller. By implementing a
simpler microcontroller we would be cutting down on the cost of using an Arduino Uno
microcontroller. The component that we would be using would be the Arduino Uno chip
that would require coding to ensure it works as we need it. A PCB with surface mount
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components would give us better accuracy due to the smaller margin of error of the
surface mount components and a more sturdy implementation of our circuit designs.
○ Pros
■ Inexpensive compared to alternatives
■ Smaller margin of error with surface mount components
■ Study implementation of circuit designs
○ Cons
■ Harder to modify
■ Harder to implement due the necessity to code
● PCB and Arduino Uno: For the implementation of our project we made some
adjustments were we decided to implement all of our circuit designs into a PCB shield for
the Arduino Uno. Essentially we created a PCB that can be connected to the Arduino
Uno, the reason for such a modification is that due to time constraints we would not be
able to fully implement the microcontroller into our PCB. At the same time we added a
section in our PCB that allowed us to modify our circuit design for our Glucose Sensor
which did not work as expected. (See Appendix D for PCB Layout).
○ Pros
■ Smaller margin of error with surface mount components
■ Study implementation of circuit designs
■ Capable of modification
■ Easier to implement
○ Cons
■ More expensive overall due to the need for a microcontroller
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Chapter 4: System Integration, Tests, and Results
4.1 PCB
In the beginning, it was imperative that our requirements would include improving overall
accuracy of the device as compared to last year while reducing the price as well. The major
decision was then made to implement our own PCB design. Including this PCB would make the
following improvements:
● Increase accuracy
● Reduce Size
● Refine usability
As a result of this decision, the overarching system to be integrated and tested first was the PCB.
Since the PCB would allow for the capability of all of our sensors to function efficiently, it was
vital that this would be the initial system to be integrated into our prototype. The finalization of
our PCB came along in the following steps:
● Recreation of circuit for each sensor on a breadboard
● Additional and various filtering
● Overall PCB design and schematic finalization
● Printing of board and soldering of components
The final PCB design is shown in Figure 4-1 below, which integrates each sensor and its various
components and attachments.

Figure 4-1: Final PCB Design with External Components
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4.2 Breadboard Iterations
There were three main circuits implemented on each breadboard: the Blood Pressure circuit
[Figure D-1], Pulse Oximetry circuit [Figure D-2], and the Glucose circuit [Figure D-3]. The
various schematics were implemented onto three separate breadboards, that allowed for simple
modification [Appendix C]. A lot of our initial predictions were obtained from the simple
calculations we performed prior to our schematic design. Blood Pressure testing was deemed
correct when we were able to fully measure patient’s data from the breadboard and the same was
done for the Pulse Oximeter. Testing for the Glucose sensor required much more custom
iterations. Once our breadboard implementations were cleared they were implemented on the
PCB to conduct further testing.
4.3 Blood Pressure
Blood Pressure testing began by utilizing our PCB design [Figure D-1 Appendix D] . Through
our testing, our accuracy with the systolic and diastolic pressures compared against the
commercial device were found to be within 3-7%, which correlates to our requirement of
improving the accuracy of this sensor as compared to last year. Various results through our
volunteers are recorded in [Table C-1].
4.4 Pulse Oximeter
Pulse Oximetry testing is shown in [Table 3-1 and 3-2]. Our breadboard testing was done by
taking data being measured through the patient’s finger, as opposed to the earlobe sensor that
would later be implemented. Our main contribution to enhancing the accuracy of this sensor was
the inclusion of the aforementioned earlobe sensor. Below in Figure 4-2 is the housing that we
created for the earlobe sensor to house the LEDs and photodiode.

Figure 4-2: Ear clamp Sensor
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We then measured patient data through this process. The heart rate recorded as compared against
our commercial product was found to be within 8% accuracy, and our blood oxygen saturation
levels all fell within 1% accuracy [Table 3-1 and 3-2].
4.5 Glucose
Glucose was the most difficult sensor to implement, and the testing required constant variation
throughout the year. Testing was done through measuring the difference between various
concentrations of pure glucose in a water solution. As shown in Figure 3-8, we began with
having these solutions in a latex balloon, which would allow for more light to go through so that
we could gain a more realistic measurement to that of the skin. As time went on, we decided to
design an opaque container with a clear opening to allow for the glucose to be seen. This
approach is shown below in Figure 4-3.

Figure 4-3: Opaque Glucose Container
This slightly increased the correlation of data read to that of the various solutions, but our group
decided to move forward and begin testing with our PCB design. We created a test pad on the
right half of the PCB to allow for alterations [Figure D-6].
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Chapter 5: Cost Analysis
Table 5-1: Overall Cost of Project
Component

Number
of Items

Price per
Unit

Total
Cost

*Order
Cost

Commercial Pulse Oximeter
Santamedical SM-240 OLED Finger
Pulse Oximeter

1

$54.95

$54.95

Commercial Blood Pressure Monitor
Omron 7 Series Upper Arm BP Monitor

1

$64.99

$64.99

Commercial Glucose Monitor
One Touch Ultra Diabetes Testing Kit One Touch Ultra Meter,
100GenUltimate Test Strips, 100 30g
Lancets, 1 Lancing Device and 100
Alcohol Prep Pads

1

$40.95

$40.95

Commercial Thermometer
Beyoung Axillary Thermometer

1

$6.99

$6.99

$178.03

Custom 4-layer circuit board from
ExpressPCB.com ( PCB boards)

3

$25.00

$75.00

$110.93

5mm Red LED (660nm)

10

$0.29

$2.90

$10.20

5mm IR LED (940nm)

10

$0.68

$6.80

$21.06

Glucose Meter LED
LED1550E - Clear Epoxy, 1550 nm,
2mW

8

$17.95

$143.60

$197.41

GPD Optoelectronics GAP 136 in GaAs
Photodiode (900-1650nm)

5

$20.00

$100.00

$191.78

TI OPT101P Photodiode (400-1100nm)

2

$7.46

$14.92

$26.71

Honeywell ASDX015PDAA5 Pressure
Transducer

1

$11.69

$11.69

$20.43

Hand Pump: Omron Digital Blood
Pressure Parts & Accessories

1

$14.95

$14.95

$14.95
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Pressure Cuff: `ComFit Cuff 9"  17" for
HEM773AC & HEM780

1

$18.95

$18.95

2nd Hand Pump: Santamedical Adult
Deluxe Aneroid Sphygmomanometer

1

$13.95

$13.95

2nd Commercial Pulse Oximeter:
Santamedical Generation 2 OLED
Fingertip Pulse Oximeter

1

$18.95

$18.95

$52.98

Condoms (for testing):Trojan ENZ
NonLubricated Condoms, 12 Count

1

$5.97

$5.97

$10.81

MATLAB and Simulink Student Suite

1

$99.00

$99.00

$99.00

Chip Components: Resistors, Capacitors,
Inductors, etc. (DigitKey.com)

See Table $23.53
of
Compone
nts

$23.53

$40.33

Arduino Mega Microcontroller

1

$40

$40

$40

Total cost: $758.03
*Including shipping and cost

Table 5-2: Cost of Device
Item

Cost

Blood Pressure
●
3Way Dump Valve
●
Handpump & Pressure Cuff
●
ASDX015PDAA5 Transducer

Total = $ 47.53
$2
$14.95 + $18.89 = $33.84
$11.69

Glucose
●
LED1550E
●
GAP 136 Photodiode
●
Spring for Ear Clamp

Total = $ 38.95
$17.95
$20
$1

Oximeter
●
TI OPT101P Photodiode
●
5mm Red LED (660nm)
●
5mm IR LED (940nm)

Total = $ 8.43
$7.46
$0.29
$0.68

PCB

$25

$1014.62

38

Arduino Uno

$40

Surface Mount Component (Res, Caps)

$4.49

Surface Mount Components (Op-Amps,
Mosfets)

$8.13

Acrylonitrile-Butadiene-Styrene (ABS)

Free*

Total Cost

$133.58 or $172.53 (Glucose)

* Donated by the Frugal Lab
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Chapter 6: Patent Search and Business Plan
Table 6-1: Patent Search
Patent ID

Patent Title

Description

US 8676284 B2

Method for non-invasive blood
glucose monitoring

Using metabolic heat
measurements to measure blood
glucose levels

Device and method for
US 20150112170 A1
non-invasive glucose monitoring

Transmission of terahertz waves
through a tissue to be received
by a sensor on the opposite side

US 8135450 B2

Noninvasive glucose sensing
methods and systems

Using electromagnetic waves or
ultrasound waves, dependent on
tissue thickness, length, width,
diameter, etc.

US 6556852 B1

Earpiece with sensors to
measure/monitor multiple
physiological variables

Pulse oximeter ear sensor
positioned against rear wall of
the ear canal

US 8588880 B2

Ear sensor

Optical assembly sensors used at
concha of the ear

Medical patient vital
signs-monitoring apparatus

Portable ultra-lightweight
multisensor including ECG,
pulse oximetry, and blood
pressure

Device for non-invasively
measuring glucose

Ear clamp noninvasive blood
glucose sensor using ultrasonic,
electromagnetic, and thermal
methods

US 5931791 A

US 8235897 B2

Business Plan
The team had initially designed our device to be sold for individual purchase in India to a certain
amount of people in a community. We were able to get into contact with NOORA Health [19],
who suggested that our business model could function as follows: Patients would only be
charged per test rather than purchasing an entire model of our device. Implementation would
then require that our components would be assembled in India, which would also reduce the
overall cost of our device. Since our device was intended to be financially responsible, this
business model functions well for our requirement.
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Chapter 7: Professional Issues and Constraints
7.1 Ethical:
A number of ethical questions needed to be raised with the development of this device. The first
question is about the access to a device like this; while it is significantly less expensive than
currently commercially available multi-sensors, it is still relatively expensive for low-income
families. As such, there is a question of whether this device contributes to the problem of access
to health care. While this device wouldn’t be that inexpensive, it is the sort of thing that multiple
users can pool money together to buy, as there is little concern for sanitation issues with respect
to this device.
Another concern to be considered is that since this device is designed to be used with mobile
devices, this doesn’t increase the access to health information for those in greatest need for
increased access. Areas in the world that do not have cell phone towers in place, or in areas
where most people are too poor to afford luxuries such as mobile devices, this device serves very
little purpose. While it does address a large population of people that could use the help of this
device, it does very little to aid the most vulnerable people in communities around the world.
One last concern is with increased access to health information such as this, there is also an
increased need for professionals who can help users interpret the data they are receiving from the
device. Similarly to getting one’s genome sequenced without the consultation of a doctor or
genetic counselor, such data can mean very little, or even cause users to form false
opinions/diagnoses of themselves, as they may not seek out the appropriate individuals that can
help users make decisions with the data they measure themselves.
7.2 Health and Safety:
Given that products such as the one produced as a result of this project are made for use by the
general public, there is a need to ensure that the product meets certain safety standards.
In general, a product should be safe enough that an adult can use the product for normal
functions without any risk of damage to their body, those around them, or any property around
them. This implicates things such as making sure it doesn’t produce too much heat, that there are
no exposed wires that could potentially shock the user, and that the light intensity produced by
the LEDs is low enough that no damage would come to the user for looking into it for a moment.
However, the assumption that there will be those who will use the device for purposes other than
that which it was made for, and a reasonable amount of precautions should be taken to prevent
harm in those functions too. This includes ensuring that there aren’t any small parts that can
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easily come off and be swallowed by infants or animals, as well as that there are no fire hazards
associated with the product.
For the sensors that involved the use of LEDs, all were checked by Santa Clara University’s
Safety staff to ensure that there is no concern associated with looking into the LEDs directly, and
that there would be no direct contact with any parts that have potential to heat up.
The question does come up, to what extent does one increase the cost of a product to cover for
safety concerns that fall outside of normal use. This becomes a problem, largely because almost
anything can be used incorrectly to cause harm to a person, so a product could never be
completely safe, so a line must be drawn to ensure that and reasonably possible concerns are
covered, such as burns, sharp edges or corners, damage to eyes, or electrical shocks.
7.3 Environmental Impact:
The primary environmental impacts as pertain to this device are the proper disposal of the
components used to make the device. On a per-use basis, this device produces no waste
whatsoever. Additionally, this device has an approximate minimum life expectancy of five years
based on the lifespan of the more fragile components. However, once the device is no longer
functional, there are a number of components that need to be disposed of properly. This includes
a number of plastics and rubbers that are used to make the housing and tubing for the device, as
well as wiring and various small electrical components (LEDs, photodiodes, capacitors, resistors,
etc.).
The production of the photodiode for the glucose sensor has an indium-gallium-arsenide alloy.
Producing this alloy involves the use of a highly toxic gas [20], which is an environmental
concern. However, once this gas is deposited onto a substrate, it is inert.
7.4 Science, Technology, and Society:
This product is targeted to communities in developing countries that are far away from hospitals
and clinics, but has implications even in developed countries where people are far away from
hospitals and clinics, but still have access to mobile devices. The development and
implementation of this device has the potential to provide communities with a greater degree of
health independence by giving users access to their vital sign information in their towns or
homes, help them save time and money by reducing the frequency of unnecessary doctor’s
appointments, and has the potential to reduce costs even of emergency medicine companies that
commonly use multi-sensors.
There are some potential negative consequences in these communities as well. Giving people
greater access to these tools does give people greater opportunities to learn to track their own
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vitals, but also leaves potential for people to do so incorrectly, and potentially key details that
result in spending money on going to see a doctor when not necessary, or avoiding the hospital
when a visit is necessary. Additionally, with an implemented telemedicine component, unless
encryption of the medical information is very well developed, there is potential for users’ health
information to be stolen through the use of mobile devices, which poses a serious risk to users, as
this data can be sold to health insurance companies.
7.5 Civic Engagement:
A medical device such as the device produced in this project would require FDA approval before
the device could be sold commercially here in the United States, and would have to go through
similar health regulation agencies in whatever country this product is to implemented in. This is
particularly true with respect to the glucose sensor portion, as the rest of the sensors are simply
cheaper/adapted forms of technologies that are already FDA approved. The glucose sensor
technology being used for the glucose sensor in this device is not yet approved by the FDA; there
are a number of companies that are in the FDA approval process at the time of this writing that
use a similar technology. This means that in the next few years as these technologies are
approved, it will be easier to push this device through as similar technologies have been
approved; the primary difference of this device is the reduced cost and simplicity. Additionally,
testing on a greater number of subjects before trying to get FDA approval would increase the
chances of receiving the approval, as data demonstrating the efficacy of the technology of this
device would be helpful, as well as tests on the safety of the glucose sensor technology as a
potential danger would be necessary for approval.
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Chapter 8: Summary and Conclusions
8.1 Conclusions
The objective of this project was to develop an affordable kit equipped with sensors that will be
used to take a patient’s vital signs, such as blood pressure, heart rate, blood glucose
concentration, and blood oxygen saturation. This kit is intended for developing countries such as
India in order to help alleviate the health care issues of people not being able to check on how
their overall health is doing. This device, in the future, could detect if a person would need to
make the arduous trip to go to the doctor. Our vital sign kit is compact and also easy to use. We
found that on average, the pulse oximeter and heart rate sensor had less than 10% error compared
to commercial products. The blood pressure sensor average is in the range between 10% -20%
compared to the commercial sensor, however, we know that our current limitation that is
preventing us from reaching less than 10% error is the Matlab code that processes the data. In the
future, that can be assessed and fixed. Furthermore, while our glucose sensor is not functional,
we have learned what new directions students could go in to make the sensor work if they chose
to continue this project.
8.2 Future Work
Some possible directions to go in the future include:
● Microcontroller Implementation: Due to time constraints we were not able to
implement the microcontroller into our PCB. While we did developed a possible
schematic for implementation, there is more work that needed to be done in terms of
coding before we got a fully functional microcontroller. Due to time constraints we opted
to continue to use the Arduino Uno as our microcontroller. For future development of the
project, a team could potentially implement this change which would bring down the
overall price of the project by getting rid of the need for an Arduino Uno. (See Appendix
D for Microcontroller Circuit Design)
● Software Development: For most of our computations we use an assortment of software
including Arduino Software and Matlab. A goal for the future is to create a iOS or
Android app that is able to do all of the necessary calculations to send the data results to
another mobile device.
● Adding in respiratory sensor.
● Using a new methodology to test glucose levels.
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Chapter 9: Ethical Analysis
When it comes to engineering, it can be easy to lose oneself in the excitement of new and
upcoming technologies. At times, however, these ideas can overshadow the equally important
concept of ethical considerations. Just as important as the newest medical treatment are the
questions that surround it, such as who has access to this treatment, whether the risks outweigh
the benefits, and other such ethical questions that helps draw the line between a “good”
technology and a “bad” one. The technology in question is the Vital Multi-Sensor Kit, which will
measure vital signs such as heart rate, blood pressure, and other baseline vitals, and be
connectable to a mobile device to be sent to a physician for diagnosis.
To start off, it is important to understand the fundamental moral argument for pursuing
the senior design project that this team is undertaking. This argument is that every person has a
fundamental dignity, and that dignity extends to a right to medical care. Basic human dignity
means treating every life as if it matters, whether that is socially, intellectually, or physically. So
long as a life matters, that means that there must be certain steps that we as people must be
prepared to take to uphold this dignity. With this in mind, we sought to make it easier for people
to get access to the health care they need, even if it is just for the sake of treating them with basic
human dignity. Beyond that yet, there are an immense number of people around the world who
take their access to healthcare for granted, primarily in the developed world. If there are so many
who believe healthcare is a right as opposed to a privilege, then we should treat it as such, and
work to defend this right for those who cannot necessarily do so themselves.
Moving onto the product itself, the ethical duty that this team has to the potential users
must be considered. Ideally, the product this team is working towards producing would target a
very large demographic, which is those who do not have easy access to a doctor or hospital, but
do have access to a smartphone or other such mobile device. This could be easily in the millions
of people. What is owed to these potential users is that the data they retrieve from the device is
accurate to the best of our ability. Inaccurate data could result in either a false sense of security
in one’s health, or an unnecessary amount of time and resources spent on getting to a hospital
when such a visit is not necessary. This is not to say that absolute accuracy can be achieved for
this product, but it is to say that it is the ethical duty of this team to work towards the greatest
accuracy given the time and resources allotted, and provide the appropriate specifications for the
percent error they would be likely to encounter. Another duty to the potential users is that the
product should be made to fulfill the requests and needs as much as possible. Given that we will
be contacting some of the potential users of this product, it is our duty to provide them with a
product that at least attempts to meet the user's’ needs, as opposed to whatever desires this team
may have for the product.
Yet another important ethical consideration when engineering a product is the risks that
may be associated with it. To the best of our ability, we are ensuring that this device would not
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be able to malfunction to the extent that it could cause physical harm. While there are a few parts
that have the potential to heat up when overused that could burn the skin, we are going to
minimize the risk of that within the circuitry of the product. This occurrence will also be
minimized by the elimination of physical contact with any electrical components that could heat
up. There is also a risk associated with the product with regards to confidentiality. Since the
purpose of this device is to collect baseline vital signs that could be indicative of health concerns,
the data retrieved by the device would be considered confidential.The purpose of this product is
to collect and send health data to a desired person via mobile device; at least in part, steps ought
to be taken to ensure that this data cannot be acquired by unauthorized viewers, which could be
accomplished with data encryption methods. This is a concern because this confidential health
data could be indicative of health concerns, which is data that is valuable to health and life
insurance companies, as well as other parties that could misuse the data. Lastly, there is the risk
brought up earlier, about the potential harms of inaccurate data. Should the product provide data
that is indicative of no health concerns when there are in reality concerns, there is potential for
the user to miss out on treatment for an ailment they may be suffering from. At the same time, if
the product provides data that is indicative of a health concern when there is no health risk, the
user may make arrangements to make their way to a hospital without the need for a potentially
costly trip.
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Appendix A: Raw Data
Heart Rate & Pulse Oximeter Data
Table A-1: Pulse Oximeter and Heart Rate Data from Trial 1.
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Table A-2: Pulse Oximeter and Heart Rate Data from Trial 2. Elevated heart rate and oxygen
saturation measurements are also shown. [SD = Senior Design Device]
Patient 0

Patient 1

Patient 2

HR

80

O2

98

HR_SD

52

O2_SD

99

HR0_elev

97

O2_elev

98

HR_SD_elev

108

O2_SD_elev

99

HR

64

O2

99

HR_SD

68

O2_SD

98

HR_elev

62

O2_elev

98

HR

95

O2

99

HR_SD

96

O2_SD

99

HR0_elev

110

O2_elev

98

HR_SD_elev

108

O2_SD_elev

98
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Blood Pressure Data
Table A-3: Trial 1 and Trial 2 of Blood Pressure Sensor Measurements
Trial 1
Person 1
Person 2
Person 2
Commercial BP:
119/77
102/70
107/72
Sensor:
110/65
98/72
100/67
% Diff (Systolic)
8%
4%
7%
% Diff (Diastolic)
16%
3%
7%
Trial 2
Commercial BP:
Sensor:
% Diff (Systolic)
% Diff (Diastolic)
Avg. Error Systolic
Avg. Error Diastolic

Person 1
116/72
92/63
21%
13%

Person 2
98/73
100/67
2%
8%
8%
7%

Person 4
103/65
98/67
5%
3%

Person 2
100/60
93/61
7%
2%

Figure A-1: This is an example graph of the blood pressure sensor readings. The beginning of the
heart rate marks the systolic pressure, and the diastolic pressure is where the heart beat ends.
Heart beats are most visibly seen around 1500 (in the x-direction).
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Glucose Sensor Data
Table A-4: Glucose Sensor Raw Data Trial 1
Trial 1
Glucose Concentration (mg/dL)
200
90
50

Signal (0 to 1023)
660
655
656

Baseline (bits)
837
839
839

Table A-5: Glucose Sensor Raw Data Trial 2
Trial 2
Glucose Concentration (mg/dL)
30
50
70
100
125
200

Signal (bits)
22
10
11
10
10
9

Baseline (bits)
735
728
722
727
705
696

Table A-6: Glucose Sensor Raw Data Trial 3
Trial 3
Glucose Concentration (mg/dL)
100
30
200
200
100
30

Signal (bits)
387
289
308
295
389
382

Baseline (bits)
696
700
700
700
670
699

Table A-7: Glucose Sensor Raw Data Trial 4
Glucose Concentration
Trial 4
(mg/dL)
30
50
70
80
90

Signal (bits)
634
636
636
634
636

Baseline (bits)
650
651
651
651
651
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Table A-8: Glucose Sensor Raw Data Trial 5
Glucose Concentration
Trial 5
(mg/dL)
50
90
125
200
Table A-9: Glucose Sensor Raw Data Trial 6
Glucose Concentration
Trial 6
(mg/dL)
50
90
125
200

Signal (bits)
408

Baseline (bits)
585

403
399
400

584
584
584

Signal (bits)
176
N/A
N/A
132

Baseline (bits)
585
584
584
584
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Appendix B: Detailed Calculations
Blood Pressure Calculations:
Blood pressure data retrieved directly from the sensor without any processing is returned in the
form of bits, ranging from 0 to 1023. These bits are directly correlated to the voltage output of
the sensor, which can be calculated using the formula:
V = (# of bits) ×

(5V )
(1023 bits)

where V is equivalent to the voltage output of the pressure sensor in volts. In order to now
retrieve a pressure value from the pressure output, the voltage must be processed through a
formula provided by the manufacturer of the pressure sensor (see Figure I-1), which is:
V out = V s × (0.018 × P + 0.04)
where Vout is representative of the voltage output of the pressure sensor in volts, Vs is
representative of the voltage provided to the sensor in volts, and P is the pressure applied to the
sensor in kilopascals (kPa). To solve for the pressure P in millimeters of mercury (mm Hg)
which is standard for blood pressure sensors in the United States, the equation is changed into:
V

out
P = ( 0.0594
− 2.222) × 7.5

where P is pressure in mmHg, and Vout is the voltage output of the pressure sensor in volts.
Then, in order to extrapolate the systolic and diastolic pressures, the pressure values of a single
trial must be graphed. On this graph, the relevant region of the data set is then identified, marked
by the appearance and subsequent disappearance of small peaks during the slow release of
pressure.
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Figure B-1: Blood pressure graph breakdown
With this relevant region identified, the first and last substantial peaks are identified. The
pressure of the first substantial peak is representative of the systolic pressure, and the pressure of
the last substantial peak is representative of the diastolic pressure. The key with this
identification of substantial peaks is the amplitude of the peaks. The very first small peaks that
appear are not consistent with the systolic blood pressure, but the first peak of a relatively
substantial amplitude is consistent with the systolic pressure (as measured against commercial
blood pressure sensors). This analysis is the same with the diastolic pressure. Since there are
variations in the amplitudes of the peaks from person to person and trial to trial, the
determination of what constitutes a significant enough amplitude to qualify as a substantial peak
is relatively subjective, which is the reason that at this point, the MATLAB code is not able to
accurately determine the systolic and diastolic pressures from the data sets. Hence, the
calculations are done through Excel and visual analysis reveals the relatively substantial peaks to
indicate the pressure values of interest.
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Appendix C: System-Level Descriptions

Figure C-1: Initial Blood Pressure Breadboard Design

Figure C-2: Pulse Ox Breadboard Implementation
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Figure C-3: Initial Glucose Breadboard Design

Figure C-4: Final PCB with all Circuits Included
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Figure C-5: Final Blood Pressure Testing

Figure C-6: Final Pulse Oximetry Testing
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Figure C-7: Continued Glucose Testing
Table C-1: Example of Blood Pressure Accuracy Comparison
Trial 1

Person 1

Person 2

Person 3

Person 4

Commercial BP

119/77

102/70

107/72

103/65

Sensor

110/65

98/72

100/67

98/67

% Difference
(Systolic)

7.6

3.9

6.5

4.9

% Difference
(Diastolic)

15.6

2.9

6.9

3.1

59

Figure C-8: Glucose PCB Implementation
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Appendix D: Circuit Designs

Figure D-1: ExpressPCB Blood Pressure Circuit Design

Figure D-2 : ExpressPCB Oximeter Circuit Design
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Figure D-3: Glucose Experimental Circuit Design

Figure D-4: ExpressPCB LED Drivers Circuit Design
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Figure D-5 : ExpressPCB Microcontroller Circuit Design

Figure D-6: PCB Layout
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Table D-1: Sensor Circuit Filters, Amplifiers, and Buffers
Blood Pressure Circuit
Type of Filter/Buffer/Amplifier

Cut Off/Gain

Low Pass

10.6 Hz

Buffer
High Pass

2.19 Hz

Non-Inverting Amplifier

101 Gain

Low Pass

10.6 Hz
Glucose Sensor Circuit

Transimpedance Amplifier

0.25Hz Cut Off/ 100 Gain
Oximeter Circuit

Buffer
Low Pass

5.89 Hz

Notch Filter

60 Hz

High Pass

0.86 Hz

Non-Inverting Amplifier

31 Gain

Low Pass

4.82 Hz

64

Appendix E: Project Management
Project Timeline:

Figure E-1: Gantt Chart of Senior Design Project (Year-long)
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IRB Application
Advisor: Dr. Ashley Kim
Students: Natalie Arrizon, Jose Hernandez, Antonio Maldonado-Liu, Alejandra Pacheco
IRB Application
Title: Vital Sensors Project
1. Purpose
Provide a brief explanation of the proposed research, including specific study hypothesis,
objectives, and rationale.
The purpose of the research is to increase accuracy with the vital sensors kit that our team is
designing. The kit will have the capability to measure up to six vital signs through the use of
around 3-4 separate sensors. Testing on human subjects will help to ensure accuracy through the
measured results that are collected through different patients. By collecting data with more
subjects, our team will be able to increase the accuracy of the measured data by altering our
original design or accounting for other setbacks or factors.
2. Background
Give relevant background (e.g., summarize previous/current related studies) on condition,
procedure, product, etc. under investigation, including citations (attach bibliography in
Attachments section) if Applicable.
In many developing countries, a large percentage of the population lacks access to adequate
healthcare. This is especially true in India where close to 70% of the population lives in rural
areas and has little to no access to hospitals or clinics. At the same time the doctor to patient ratio
is of 0.6 to 1000.
Telemedicine has slowly been implemented in India to make doctors more available for patients
through the use of video conferences and other forms of communication. However, a
shortcoming of this is that the doctor still has no direct access to a patient's information, other
than descriptions, x-rays, etc.
Around 80% of the population in India owns some form of mobile device, only 30% of those
devices are smartphones. This percentage is expected to increase. Currently India is the second
largest smartphone market globally.
In 2016, a team of Santa Clara students designed a vital sensory kit that could be connected to a
computer to measure vital signs. The device was able to measure blood pressure, oxygen
saturation, and heart rate with an average of 13% error. This year, we seek to produce a device
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with reduced error, and that has the capability to connect to a mobile phone for mobile vital sign
monitoring.
3. Collaborative Research
N/A
4. Qualifications of Study Personnel
a) There are four students working on this kit who have qualifications well suited for the
project. Two bioengineering majors help provide knowledge on how to work with the
medical sensors and have the capability to read and distinguish proper results. One of the
bioengineers is also EMT certified. The two electrical engineers are experienced in
designing various types of circuitry and filter design.
b) The students have taken ELEN 21, ELEN 50, and other electrical engineering courses
that are relevant to designing the proper circuit models and analyzing data that is
collected. ELEN 21 is about logic design, and ELEN 50 is an introductory course to
electricity and circuits. The two electrical engineering majors are also experienced in
designing PCB boards and have training in the use of oscilloscopes, multimeters, bread
boards, sensors, and other relevant programming. The bioengineering students have taken
BIOE 163, which prepares students with the fundamentals for device engineering in the
industry and BIOE 162, a class geared towards understanding signals and signal
processing with Matlab. All members of the team are capable with working with patients
in a professional and friendly manner to carry out the research necessary.
5. Subject Population
a) Describe proposed subject population, stating age range, gender, race, ethnicity, language and
literacy.
The population we will be testing mostly consists of university students of an age range of 18-24.
The expected sample of subjects will be chosen so that there is a diverse range of races,
ethnicities and ages, and sex.
b) State total number of subjects planned for the study and how many must be recruited to obtain
this sample size. Explain how number of subjects needed to answer the research question was
determined.
The total number of subjects that will be tested will be 30. We will be recruiting 30 subjects to
obtain the sample size. The amount of subjects to be tested was determined based on the time
constraints of the project.
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c) If any proposed subjects are children/minors, prisoners, pregnant women, those with physical
or cognitive impairments, or others who are considered vulnerable to coercion or undue
influence, state rationale for their involvement.
NA
6. Recruitment
a) Explain how, where, when, and by whom prospective subjects will be identified/selected and
approached for study participation. If researcher is subject's instructor, physician, or job
supervisor, or if vulnerable subject groups will be recruited, explain what precautions will be
taken to minimize potential coercion or undue influence to participate.
Subjects will be randomly selected and approached during daylight hours at Santa Clara
University. Each team member will also ask their friends or acquaintances to participate in the
study. We will be conducting the tests in a non-agitating environment. Some subjects will be
asked to exercise before testing. Over the period of time between January 2017 to March 2017.
b) Describe any recruitment materials (e.g., letters, flyers, advertisements [note type of
media/where posted], scripts for verbal recruitment, etc.) and letter of permission/cooperation
from institutions, agencies or organizations where off-site subject recruitment will take place
(e.g., clinic, school district). Attach these documents in Attachments section.
We will be asking most subjects in an informal manner to participate in the testing of our device.
Verbal confirmation will be the only thing needed as each subject being approach is a consenting
adult.
7. Screening
a) Provide criteria for subject inclusion and exclusion. If any inclusion/exclusion criteria are
based on gender, race, or ethnicity, explain rationale for restrictions. Provide criteria for subject
inclusion and exclusion. If any inclusion/exclusion criteria are based on gender, race, or
ethnicity, explain rationale for restrictions.
a) The goal is to have a diverse group to conduct our research on. We would like to have
about a 50% male 50% female ratio to help detect any nuances in heart rate or blood
pressure, should there be any. Our subjects will also be more varied based on age as to
get a broad spectrum of results to improve accuracy within the device.
b) If prospective subjects will be screened via tests, interviews, etc., prior to entry into the
"main" study, explain how, where, when, and by whom screening will be done. NOTE: Consent
must be obtained for screening procedures as well as "main" study procedures. As appropriate,
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either: 1) create a separate "Screening Consent Form;" or 2) include screening information within
the consent form for the main study.
b) There will be no screening conducted prior to the study.
8. Compensation and Costs
a) Describe plan for compensation of subjects. If no compensation will be provided, this should
be stated. If subjects will be compensated for their participation, explain in detail about the
amount and methods/ terms of payment.
There will be no compensation for students. Students will participate in study on a volunteer
bases.
9. Study Procedures
a) Before any subject is tested they will be fully informed of the experiment, what we are
doing for our project, the exact procedure they will be participating in, as well as offer an
answer to any other question they might have. Without question, any subject that feels
cautious or uncomfortable about participating in our study are advised not to participate.
The patient then must also sign a consent form in order to participate in the experiment.
1. We will first measure the resting heart rate, blood pressure, glucose and oxygen
saturation levels simultaneously, temperature, and finally elevated heart rate. The testing
will be performed by Alejandra Pacheco, Natalie Arrizon, Jose Hernandez, or Antonio
Maldonado-Liu unless otherwise specified. The testing will occur in Benson 1, in the
basement of the Benson Center, with the exception of the blood glucose testing, which is
to occur in the Cowell Center, as stated below. Testing will occur in the window of
January 2017 - March 2017, between 9am - 5pm on any day of the week. Each patient
will be tested no more than twice total, no more than once per week. The testing process
itself should be under one hour, with the informing and consent form signing taking
approximately fifteen minutes. There will be no deception or lack of full disclosure, and
no audio or video recording.
a. Elevated Heart Rate: to achieve this condition, we will ask the subject to perform
any activity of their choice that will elevate their heart rate (i.e. push-ups, jog in a
circle, high-knees, walking, etc.) for 1 minute.
Resting Heart Rate: When taking readings from this condition, we will ask the
subject to sit comfortably and to relax for 2 minutes so that they are as close to a
resting heart rate as possible. This will likely be done first, prior to the other two
conditions which should likely elevate the heart rate.
b. Once the desired state is achieved,
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2. Blood Pressure: The blood pressure cuff is placed on the non-dominant upper arm of the
patient, with the sensor over the brachial artery. Antonio Maldonado-Liu will then use the
hand pump to manually inflate the blood pressure cuff to approximately 160mmHg, at
which point the slow release of the air pressure will be activated, and the device will
measure the patient’s blood pressure. After 2 minutes, the patient’s dominant arm will be
tested with a commercial blood pressure device, also by Antonio.
3. **Glucose levels: The measuring component for this and the pulse oximetry are the
same. The earlobe component is applied to the earlobe of the patient. The measuring will
be activated, and the device will measure the blood glucose levels non-invasively and
spectroscopically.
4. Oxygen saturation: With the earlobe sensor in place on the patient’s earlobe, the
measuring is activated. The device will then measure the blood oxygen saturation of the
patient spectroscopically (industry standard). The patient’s blood oxygen saturation is
simultaneously measured using a commercial finger pulse oximeter on the middle finger
of their right hand.
5. Temperature degree: The patient places the thermometer in the armpit of the right arm,
and the patient holds the thermometer in position with the right arm. The thermometer is
then activated and is left in place until a stable temperature reading is reached (no change
in temperature reading for 5 seconds). This measurement is taken simultaneously with a
commercial axial thermometer in the patient’s left armpit.
**The non-commercial blood glucose monitor that we are using in our device is experimental.
Traditional commercial blood glucose devices require the exposure of blood in order to
invasively measure the blood glucose concentration enzymatically. Our blood glucose device
instead uses a near-infrared LED and a corresponding photodiode to measure the transmittance
of the light through the earlobe tissue without the necessity of exposing any blood, and is in this
way completely non-invasive.
Final note: We are in the process of designing and building a prototype of each sensor and will
produce a final prototype for testing patients. The project timeline is attached in the form of a
Gantt Chart.
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School of Engineering Budget Proposal
Vital Multi-Sensor Kit, Funding Proposal
Group Members
Name

Major

Email

Alejandra Pacheco (Primary)

BIOE

a2pacheco@scu.edu

Antonio Maldonado-Liu

BIOE

acmaldonadoliu@scu.edu

Jose Hernandez

ELEN

jhernandez@scu.edu

Natalie Arrizon

ELEN

narrizon@scu.edu

Ashley Kim

BIOE Advisor

ukim@scu.edu

Tokunbo Ogunfunmi

ELEN Advisor

togunfunmi@scu.edu

Our Vision to Give Developing Countries Tele-mobile Access to Healthcare
The purpose of the Vital Sensors Kit is to be inexpensive and accessible to people in rural areas
of developing countries, where there is no easy access to medical care. The kit is aimed to be a
simple and affordable medical device that monitors vital signs such as blood pressure, blood
oxygen concentration, heart rate, respiratory rate, blood glucose, and temperature without the
need for a doctor’s immediate assistance. In such scenarios, this device would replace the first
steps of any standard medical checkup. Instead of traveling all the way to a hospital to have
baseline vitals measured, you would measure them with this device, and send them to a
physician for review to help determine whether an in-person appointment is necessary. This
frugal device gives under-resourced families the opportunity to take care of their health and live
a better life.
By having a medical kit that takes many important vital signs, even people who do not have
insurance or easy access to a hospital will be able to monitor their own vital signs and those of
their family members. This solution is better than others currently available because it is much
smaller, cheaper, and more intuitive in design and use. Current devices include those carts that
are used in most hospitals here in the US, that are about 3 feet tall, and probably cost well into
the hundreds of dollars, if not over a thousand. There are a number of other available devices,
but they are expensive, and generally only have one or two types of sensors. The proposed
device is targeted to cost no more than $150, will contain at least four sensor types, and be
connectable to a mobile device such that data can be sent wirelessly to a physician via Wi-Fi or
SMS. Communities can share multiple vital sensor kits and split costs accordingly to make the
device even more affordable. We strongly believe that by making this device low-cost and
simple to use for developing countries, communities and families will be much happier and
healthier because they will be able to get the medical attention they need from doctors without
having to have the financial burden of paying for multiple hospital visits and transportation costs.
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List of Funding Sources
●

Undergraduate SOE Funding
○ $606

Budget
Item

Number of
Items

Price per
Unit

Anticipated
Total Cost

Commercial Pulse Oximeter (for comparison
to created pulse oximeter)
Santamedical SM-240 OLED Finger Pulse
Oximeter

1

$46

$46

Commercial Blood Pressure Monitor (for
comparison to created blood pressure
monitor)
Omron 7 Series Upper Arm BP Monitor

1

$75

$75

Commercial Glucose Monitor (for comparison
to created glucose meter)
One Touch Ultra Diabetes Testing Kit One Touch Ultra Meter, 100GenUltimate
Test Strips, 100 30g Lancets, 1 Lancing
Device and 100 Alcohol Prep Pads

1

$41

$41

Commercial Thermometer (For comparison to
created thermometer)
Beyoung Axillary Thermometer

1

$18

$18

Commercial Stethoscope
Omron Sprague Rappaport Stethoscope

1

$14

$14

Electret Microphone
COM-0835 ROHS

5

$1.00

$5

Custom 2-layer circuit board from
ExpressPCB.com ( PCB boards)

3

$25

$75

5mm Red LED (660nm)

10

$0.30

$3

5mm IR LED (940nm)

10

$0.80

$8

Glucose Meter LED
LED1550E - Epoxy-Encased LED, 1550 nm,

5

$18

$90
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2.0 mW, T-1 ¾
GPD Optoelectronics GAP 136 in GaAs
Photodiode (900-1650nm)

1

$25

$25

TI OPT101P Photodiode (400-1100nm)

2

$7.50

$15

Thermistor:
TI LMT70A Analog Temperature Sensor

5

$2.80

$14

Honeywell ASDX015PDAA5 Transducer

1

$44

$44

Silver (415) - Sport Knitting Wool & Yarn

1 roll

$7

$7

Dritz 9507B Non-Roll Woven Elastic, Black,
1-Inch

2.5 yards

$3

$3

Meguiar's W0004 Foam Applicator Pad 4-1/2"

4

$4

$4

3Way Dump Valve

2

$2

$4

Valve Noninverting OpAmp

2

$1.50

$3

Handpump

5

$1

$5

Chip Components: Resistors, Capacitors,
Inductors, etc. (DigitKey.com)

As needed

Resistors:
$10
Capacitors:
$10
Inductors:
$10
Other:
$10

$40

Arduino Mega Microcontroller

1

$40

$40

Breadboard

1

$9

$9

Total cost:

$588

Shipping and taxes $110
Total cost:

$698

Total amount requested from SOE: $698
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School of Engineering Participation Statement
We all recognize and commit to presenting our project in poster form at Family Weekend in
February, as well as Preview Weekend and Spring Engineering Education Days in April, should
the Dean’s Office commit any funds to this project.
Team Member Signatures
_______________________________________________
_______________________________________________
_______________________________________________
_______________________________________________
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Advisor Approval Statement
I have reviewed and approve of the above budget proposal to the School of Engineering for the
Senior Design Thesis.
______________________________________________

Date:_____________________

______________________________________________

Date:_____________________
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Meeting Minutes
10.04.16
Members Present: Antonio, Natalie, Jose, Alejandra
-

Setting up meeting with Uma and Makenzie at 1:45 in Engineering Design.
Meet with Dr. Ogunfumi at 4 pm; EC

Meeting with Dr. Ogunfumi
- He will send us the thesis where students used body signals to make music.
Try to a
 im high and think of a lot of improvements/changes to make: creativity brainstorm
session.
- Tuesday meetings 11:15 to 11:45 with Dr. Ogunfumi

10.11.16
Ideas:
Tony:
Jose:
●
●
●

Making the pulse oximeter sensor (ring, on the ear lobe)
Respiratory rate sensor (to figure out at least if something is wrong)
ECG for developing countries (3 electrodes)
Calibration-free Pulse Oximeter
Reduce the cost of the components
- Get a smaller microcontroller
Improve the accuracy of the sensors (look into doing more human testing)
Adding another sensor (respiratory rate)
Improving efficiency and speed of the code
Detectable by mobile device
Make your own PCB
Using Arduino UNO??
We finally met with the EWH people and they are going to try to help us.
Recommend taking: Mechatronics (winter), VSP (spring),
Dr. Kim is going to contact us with the files available

10.18.16
● SOE Funding Proposal - due 10/21
● Finally got access to Google Drive
To-Do’s:
- Look at Neo Panda website
- Look into Google Drive folders and look into what they did.
- Preliminary designs.

80

10.20.16
-

Contact Elizabeth to get to them.
Set up an interview with questions that are needed.
- Specific diseases or groups
Look into similar organizations
Build design prototype and order everything by Christmas break.
Add in Arduino and also other sensors for respiratory rate.
Electrodes for respiratory rates.

10.27.16
● Email SWASTH
● Email Roberto Clemente Clinic
● Email Noora Health
○ Cc Dr. Kim
○ Having them finding the non-profit.
○ Having them both be on the call.
● No change in parameters yet.
To Do:
● Contact Noora Health directly and indirectly
● Start ordering components
● Global Innovation Exchange
11.12.16
Ear piece that would have both the pulse oximeter reading and the glucose reading
What plastics are used for pulse oximeters? We don’t want the photodiode to overheat.

11.17.16
Still need to meet with Noora Health and HeMoClo people ***
Still need to decide what the goals are for the respiratory rate.
Work on the IRB application
11.30.16
Goals:
Start IRB Application
Come up with questions for meeting with Katy
Edit future timeline (for winter break)
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02.01.17
Accomplishments:
Set up meeting dates with advisor
Created weekly goals for the quarter
Started the SolidWorks design.
Turned in the IRB application for human testing.
Goals:
Finish the SolidWorks design by next week and get trained in the Maker Lab to be able to print
the products.
Start testing commercial equipment.

82

Santa Clara University Bioengineering Department
Vital Multi-Sensor Kit Consent Form
Explanation
Alejandra Pacheco, Antonio Maldonado-Liu, Jose Hernandez and Natalie Arrizon are
bioengineering and electrical engineering students, working together as a senior design team here
at Santa Clara University under the direction of Dr. Ashley Kim. We are conducting a research
study to verify the validity of the four sensors we built to make up one affordable vital sensor kit
for developing countries. Thirty subjects total will be tested. Each subject’s heart rate, blood
oxygen saturation and pressure will be measured with the vital sensor kit device and then
measured again with the commercial devices. The glucose concentration will be measured
non-invasively only with our ear sensor.
We are requesting your participation, which will involve the use of two blood pressure sensors,
two pulse oximeters (one on your finger, one on your earlobe), and an experimental non-invasive
blood glucose sensor which will also go on your earlobe. Each testing session will take no more
than forty-five minutes, and you will be tested no more than once per week, a maximum of twice
total. Your participation in this study is voluntary. If you choose not to participate or to
withdraw from the study at any time, there will be no penalty. It will not affect your grade or
status with the university. In addition, we will ensure that all health data will remain private. If
you choose to sign the consent form, we will assign a number to your name. During testing
periods, we will record all data according to your given number. Our advisor Dr. Kim will have
the list of names-to-numbers and will be the only one to access the data. Upon completion of this
project, the list will be destroyed. The results of the research study may be published, but your
name will not be used.
The procedure is as follows:
The subject will be fully informed of the experiment, including what we are doing for our
experiment, why we are doing it, as well as how each of the sensors works. Any questions that
the subject has prior to beginning the measurements will be answered. To reiterate, should the
subject at all uncomfortable with any part of the experiment or procedure, they are advised not to
participate.
Resting heart rate: When taking readings from this condition, we will ask the subject to sit
comfortably and to relax for 2 minutes so that they are as close to a resting heart rate as possible.
Both pulse oximeters, one to the middle finger of the right hand, and the other to the earlobe, will
be applied simultaneously to measure the heart rate of the subject in this state.
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Elevated heart rate: To achieve this condition, we will ask the subject to perform any activity of
their choice that will elevate their heart rate (i.e. push-ups, jog in a circle, high-knees, walking,
etc.) for 1 minute. The pulse oximeters will then be applied in the same fashion as the resting
heart rate condition, to record the heart rate of the subject.
Blood oxygen saturation: This measurement will occur at the same time as the resting heart rate
measurement. With the subject resting and breathing normally, their blood oxygen saturation will
be recorded via the pulse oximeters already reading the subject’s heart rate.
Blood pressure: The blood pressure cuff is placed on the non-dominant upper arm of the patient,
with the sensor over the brachial artery. Antonio Maldonado-Liu will then use the hand pump to
manually inflate the blood pressure cuff to approximately 160 mmHg, at which point the slow
release of the air pressure will be activated, and the device will measure the patient’s blood
pressure. After 2 minutes, the patient’s dominant arm will be tested with a commercial blood
pressure device, also by Antonio. The commercial device performs the same procedure in an
automated fashion.
Blood glucose concentration: The measuring component for this and the pulse oximetry are the
same. The earlobe component is applied to the earlobe of the patient. The measuring will be
activated, and the device will measure the blood glucose levels non-invasively and
spectroscopically.
The testing will occur in Benson 1, in the basement of the Benson Center.
Risks and Discomforts
Participation in this experiment is completely voluntary. If you choose not to participate or to
withdraw from the study at any time, there will be no penalty. It will not affect your grade or
status with the university. You may choose to cease the experiment at the elevated heart rate
measurement, as the exercise may be uncomfortable for you. Once again, withdrawal at this
stage or any other for any reason will have no penalty upon you.
Benefits of our Research
Although there may be no direct benefit to you, the possible benefit of your participation will be
furthering the progress towards making blood glucose monitoring completely painless. In
addition, this product seeks to increase accessibility of health data and ease health monitoring at
a lower cost to the user. There will also be increased communication between health
professionals and patients, for an overall reduction in unnecessary visits to the hospital and
potentially increased health consciousness.
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Confidentiality
The results of this research study may be published, but your name will not be used. In order to
maintain confidentiality of your records, at the beginning of the data collection process, we will
only have the number matching the subject’s name. This will allow us to omit the names of the
subjects in every part of the experiment and thesis. No names will be written down, and all
consent forms collected will be delivered to Dr. Ashley Kim of Santa Clara University’s
Bioengineering Department, separate from the data and all other components of the experiment.
This will be done to keep the subject’s identity and data confidential.
If you have any questions about your rights as a subject/participant in this research, or if you feel
you have been placed at risk, you can contact the Chair of the Human Subjects Committee,
through Office of Research Compliance and Integrity at (408) 554-5591.
Inquiries
If you have any questions or doubts, please ask us for explanations. If the subject has any
questions regarding the design they may call Alejandra Pacheco at (408) 667-6770. Or, our
advisor, Dr. Ashley Kim, may be contacted at (408) 554 - 2760.
CALIFORNIA EXPERIMENTAL SUBJECTS BILL OF RIGHTS
As a research participant you have the following rights. These rights include but are not limited
to the participant's right to:
● be informed of the nature and purpose of the experiment;
● be given an explanation of the procedures to be followed in the medical experiment, and
any drug or device to be utilized;
● be given a description of any attendant discomforts and risks reasonably to be expected;
● be given an explanation of any benefits to the subject reasonably to be expected, if
applicable;
● be given a disclosure of any appropriate alternatives, drugs or devices that might be
advantageous to the subject, their relative risks and benefits;
● be informed of the avenues of medical treatment, if any available to the subject after the
experiment if complications should arise;
● be given an opportunity to ask questions concerning the experiment or the procedures
involved;
● be instructed that consent to participate in the medical experiment may be withdrawn at any
time and the subject may discontinue participation without prejudice;
● be given a copy of the signed and dated consent form; and
● be given the opportunity to decide to consent or not to consent to a medical experiment
without the intervention of any element of force, fraud, deceit, duress, coercion or undue
influence on the subject's decision.
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Representation of Health and Assumption of Risk
I have read the foregoing information, and I understand the exercise procedures that I will be
asked to perform. I agree to participate in exercise. I warrant and represent that I am in good
health and that I am able to physically perform the exercise required of me. Knowing the risks, I
hereby agree to assume such risks and to release and hold harmless all persons and entities that
might be liable to me, my heirs, or assigns for damages. All questions have been answered to my
satisfaction.
In order to achieve the elevated heart rate described above, we will ask the subject to perform
any activity of their choice that will elevate their heart rate (i.e. push-ups, jog in a circle,
high-knees, walking, etc.) for 1 minute.
Are you fit to perform this activity? Check one that applies to you. ☐ Yes ☐ No
Freedom of Consent
I have also been informed that the information derived from this procedure is confidential and
will not be disclosed to anyone other than the researchers involved with this study. The
information obtained, however, may be used for a statistical or scientific purpose with my right
of privacy retained by not disclosing any identifying information.
Participant Name: ___________________________________________
Signature:_________________________________________________

Date: ____________

Person Obtaining Consent
I attest that the requirements for informed consent for the medical research project described in
this form have been satisfied – that the subject has been provided with the experimental
Subject’s Bill of Rights, if appropriate, that I have discussed the research project with the subject
and explained to him or her in non-technical terms all of the information contained in this
informed consent form, including any risks and adverse reactions that may reasonably be
expected to occur. I further certify that I encouraged the subject to ask questions and that all
questions asked were answered.
Signature of Person Obtaining Consent:
__________________________________________

Date: ____________

86

Appendix F: Electrical Components
Component Tables:
Oximeter Filter
C1

270pf

C2

10uf

C3

0.22uf

C4

0.1uf

C5

0.1uf

C6

3.3uf

C7

5600pf

C8

10uf

C9

0.1uf

C10

1uf

R1

1.2k

R2

10k

R3

4.7M

R4

2.7k

R5

27k

R6

27k

R7

14k

R8

56k

R9

150k

R10

4.7M

R11

3.3k

R_Vres_1

10k

R_Vres_2

10k
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Transimpedance Op
213

http://www.ti.com/general/docs/lit/getliterature.tsp?genericPart
Number=opa381&fileType=pdf

LEDs Drivers
R_LED1m

1k

R_LED2m

1k

R_LED3m

1k

R_LED1

47

R_LED2

110

R_LED3

110

MMBT2222ALT1G

http://www.onsemi.com/pub_link/Collateral/MMBT2222LT1-D.
PDF

J_oxi, J_LED,
J_Photo

Connectors provided by the soldering lab
Blood Pressure

C12

1uf

C13

2.2uf

C14

1uf

C15

0.1uf

C16

1uf

R12

15k

R13

33k

R14

15k

R15

1k

R16

100k

R19

17.4k

R20

10k

C18

270pf

C19

10uf

C21

0.1uf
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C22

0.1uf

C23

3.3uf

C24

5600pf

C25

10uf

C26

0.1uf

C27

1uf

C28

10uf

R21

1.2k

R22

10k

R23

4.7M

R24

2.7k

R25

27k

R26

27k

R27

14k

R28

56k

R29

150k

MCP6004

http://ww1.microchip.com/downloads/en/DeviceDoc/21733j.pdf

Order Information Links:
Resistor
Value

Resistors
Amount Cost Per Unit

Resistor DigiKey links

47

1

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-0747RL/31
1-47JRCT-ND/729431

110

2

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0603JR-07110RL/3
11-110GRCT-ND/729649

1k

7

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-071KL/31
1-1.0KJRCT-ND/729355

1.2k

2

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-071K2L/3
11-1.2KJRCT-ND/729358

2.7k

2

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-072K7L/3
11-2.7KJRCT-ND/729385

3.3k

2

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0603FR-073K3L/3
11-3.30KHRCT-ND/730073

10k

7

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-0710KL/3
11-10KJRCT-ND/729365
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14k

2

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402FR-0714KL/3
11-14.0KLRCT-ND/729487

15k

1

$0.10

http://www.digikey.com/product-detail/en/panasonic-electronic-compo
nents/ERJ-2RKF1502X/P15.0KLCT-ND/194186

17.4k

1

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402FR-0717K4L/
311-17.4KLRCT-ND/729494

27k

4

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-0727KL/3
11-27KJRCT-ND/729398

33k

1

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-0733KL/3
11-33KJRCT-ND/729415

56k

2

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-0756KL/3
11-56KJRCT-ND/729442

110k

1

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-07110KL/
311-110KJRCT-ND/729366

150k

2

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-07150KL/
311-150KJRCT-ND/729372

1M

1

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402FR-071ML/31
1-1.00MLRCT-ND/729462

4.7M

4

$0.10

http://www.digikey.com/product-detail/en/yageo/RC0402JR-074M7L/Y
AG3304CT-ND/5282170

Capacitor
Value

Capacitor
Amount Cost Per Unit

Capacitor DigiKey Links

270pf

2

$0.19

http://www.digikey.com/product-detail/en/murata-electronics-north-a
merica/GRM1555C1H271FA01D/490-10686-1-ND/5251419

5600pf

2

$0.32

http://www.digikey.com/product-detail/en/kemet/C0603C562J5RACT
U/399-7942-1-ND/3471665

0.1uf

13

$0.10

http://www.digikey.com/product-detail/en/murata-electronics-north-a
merica/GRM155R71C104KA88J/490-6328-1-ND/3845525

0.22uf

2

$0.10

http://www.digikey.com/product-detail/en/taiyo-yuden/JMK063BJ224
MP-F/587-1819-1-ND/1465289

1uf

4

$0.10

http://www.digikey.com/product-detail/en/taiyo-yuden/JMK105BJ105
KV-F/587-1231-1-ND/931008

2.2uf

2

$0.10

http://www.digikey.com/product-detail/en/murata-electronics-north-a
merica/GRM155R61A225KE95D/490-10451-1-ND/5026361

3.3uf

2

$0.26

http://www.digikey.com/product-detail/en/kemet/C0805C335K8PACT
U/399-3129-1-ND/551634

10uf

10

$0.12

http://www.digikey.com/product-detail/en/murata-electronics-north-a
merica/GRM155R60G106ME44D/490-10693-1-ND/5251412
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Appendix G: Printed Housing Designs

Figure G-1: Device Housing Design

Figure G-2: Device Housing Lid Design
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Figure G-3: Ear Sensor LED Housing Design

Figure G-4: Ear Sensor Photodiode Housing Design
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Appendix H: MATLAB and Arduino Code
Arduino Code
#define Led1 13
#define Led2 12
int senRead=5; //The pin from which data is read. 5 for pulse oximeter, 2 for blood pressure.
int val= 0;
int i=0;
int PulseOx[500];
int Adata = 0;
int Bdata = 0;
int C = 0;
void setup() {
pinMode(Led1, OUTPUT); //pin3 Output
pinMode(Led2, OUTPUT); //pin2 Output
Serial.begin(4800); // reads data at 19200 bits
Serial.println("CLEARDATA"); //clears up any data left from previous projects
Serial.println("LABEL,Acolumn,Bcolumn,..."); //always write LABEL, so excel knows the
next things will be the names of the columns (instead of Acolumn you could write Time for
instance)
Serial.println("RESETTIMER"); //resets timer to 0
}
void loop() {
BlinkLed1(500);
BlinkLed2(1000);
int val=analogRead(senRead);
Serial.println(val);
}
void BlinkLed1 (int interval){
static long prevMill = 0;
if (((long)millis() - prevMill) >= interval){
prevMill = millis();
digitalWrite(Led1, !digitalRead(Led1));
}
}
void BlinkLed2 (int interval){
static long prevMill = 500;
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if ((millis() - prevMill) >= interval){
prevMill = millis();
digitalWrite(Led2, !digitalRead(Led2));
}
if ( Serial.available() > 0 ) {
int Adata = Serial.read();
Serial.print(Adata);
}
if ( Serial.available () > 0) {
int Bdata = Serial.read();
Serial.print(Bdata);
}
if ( Serial.available () > 0 ) {
int C = Serial.read();
Serial.print(C);
}
Serial.print("DATA,TIME,TIMER,"); //writes the time in the first column A and the time since
the measurements started in column B
}
MATLAB Code
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Appendix I: Datasheets

Figure I-1: Part of Datasheet for Pressure Sensor.

Figure I-2: Part of Datasheet for Glucose Photodiode.

